Effects of recombinant plasminogen activator inhibitor type 1 on fibrinolysis in vitro and in vivo
- 30 June 1990
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 59 (2) , 309-317
- https://doi.org/10.1016/0049-3848(90)90133-w
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits.Journal of Clinical Investigation, 1989
- Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterizationEuropean Journal of Biochemistry, 1987
- Plasminogen activator inhibitor: a regulator of ancrod-induced fibrin deposition in rabbitsBlood, 1987
- Plasminogen activator inhibitorsBlood, 1987
- Demonstration of a fast-acting inhibitor of plasminogen activators in human plasmaBlood, 1984
- Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditionsThrombosis Research, 1984
- An experimental model of in vivo fibrinolysisThrombosis Research, 1976
- A Group of Patients with Impaired Plasma Fibrinolytic System and Selective Inhibition of Tissue Activator‐Induced FibrinolysisScandinavian Journal of Haematology, 1966